Human Newborn Bacille Calmette–Guérin Vaccination and Risk of Tuberculosis Disease: A Case-Control Study

Abstract

An incomplete understanding of the immunological mechanisms underlying protection against tuberculosis (TB) hampers the development of new vaccines against TB. We aimed to define host correlates of prospective risk of TB disease following bacille Calmette–Guérin (BCG) vaccination.

Description

Citation

Fletcher, H. A., Filali-Mouhim, A., Nemes, E., Hawkridge, A., Keyser, A., Njikan, S., ... & BCG study team. (2016). Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study. BMC medicine, 14, 1-13.https://doi.org/10.1186/s12916-016-0617-3

Endorsement

Review

Supplemented By

Referenced By